Concepedia

Cindy Cázares-Körner

CC

5

Publications

220

Citations

5

H-Index

2013

Active since

Affiliations

University of Oxford(Current)

Science for Life Laboratory

Karolinska Institutet

CRUK/MRC Oxford Institute for Radiation Oncology

Uppsala University

Cindy Cázares-Körner is an author at University of Oxford specializing in medicine, pharmacology, and drug discovery.

Top concepts

MedicinePharmacologyDrug DiscoveryMedicinal ChemistryBiochemistryChemical BiologyDrug DevelopmentNatural SciencesPharmacotherapyBioorganic Chemistry

Publications per year

2013–2017

5

Publications

5

Design, synthesis and evaluation of molecularly targeted hypoxia-activated prodrugs

Liam O’Connor, Cindy Cázares-Körner, Jaideep Saha et al. · Nature Protocols · 2016 · 82 citations

Medicinal Chemistry, Pharmaceutical Science, Medicine +4

CH-01 is a Hypoxia-Activated Prodrug That Sensitizes Cells to Hypoxia/Reoxygenation Through Inhibition of Chk1 and Aurora A

Cindy Cázares-Körner, Isabel M. Pires, I. Diane Swallow et al. · ACS Chemical Biology · 2013 · 65 citations · Full text

Aurora A, Hypoxic Cells, Redox Biology +21

Efficient synthesis of 2-nitroimidazole derivatives and the bioreductive clinical candidate Evofosfamide (TH-302)

Liam O’Connor, Cindy Cázares-Körner, Jaideep Saha et al. · Organic Chemistry Frontiers · 2015 · 28 citations

Combinatorial Chemistry, Bioorganic Chemistry, Pharmacotherapy +17

Piperazin-1-ylpyridazine Derivatives Are a Novel Class of Human dCTP Pyrophosphatase 1 Inhibitors

Sabin Llona‐Minguez, Andreas Höglund, Artin Ghassemian et al. · Journal of Medicinal Chemistry · 2017 · 25 citations · Full text

Bioorganic Chemistry, Aldo-keto Reductase, Pharmacotherapy +17

Identification of Triazolothiadiazoles as Potent Inhibitors of the dCTP Pyrophosphatase 1

Sabin Llona‐Minguez, Andreas Höglund, Elisée Wiita et al. · Journal of Medicinal Chemistry · 2017 · 20 citations · Full text

Medicinal Chemistry, Systems Biology, Dctp Pyrophosphatase 1 +15

Rows per page

1–5 of 5